Scorpius BioManufacturing is an integrated CDMO focused on rapidly advancing mammalian and microbial biologic programmes to the clinic and beyond. With end-to-end capabilities from discovery to limited-scale commercial production, the company provides a broad array of R&D, analytical testing, and manufacturing services to pharmaceutical and biotech companies. With an experienced team and new, purpose-built, U.S. facilities, Scorpius is dedicated to easily accessible, transparent collaboration and flexible biologics biomanufacturing.

Services include:
- Biologics
- Cell and Gene Therapy
- Assay Development
- Bioprocessing
- Contract Manufacturing (CMO)
- Fermentation
- Manufacturing
- Microbial-based Therapeutic Proteins
- Proteins
- Vaccines
- Process Development
- Quality QA/QC
- Technology Transfer
- Protein and Peptide
- Analytical Services

Scorpius BioManufacturing is committed to delivering high-quality biomanufacturing solutions tailored to meet the diverse needs of its clients. For more information, please visit scorpiusbiologics.com.